Inhibition of HMGB1 improves experimental mice colitis by mediating NETs and macrophage polarization
Authors:
Abstract
No abstract availableKeywords
Funding Information
- Shanghai Municipal Health Commission (WX21Q13)
- National Natural Science Foundation of China (82100559)
This publication has 31 references indexed in Scilit:
- Ulcerative colitisThe Lancet, 2017
- HMGB1 exacerbates experimental mouse colitis by enhancing innate lymphoid cells 3 inflammatory responses via promoted IL-23 productionInnate Immunity, 2016
- HMGB1 Inhibition During Zymosan-Induced Inflammation: The Potential Therapeutic Action of RiboflavinArchivum Immunologiae et Therapiae Experimentalis, 2015
- HMGB1 promotes the activation of NLRP3 and caspase-8 inflammasomes via NF-κB pathway in acute glaucomaJournal of Neuroinflammation, 2015
- Chronic Kidney Disease Causes Disruption of Gastric and Small Intestinal Epithelial Tight JunctionAmerican Journal of Nephrology, 2013
- NLRP12 Suppresses Colon Inflammation and Tumorigenesis through the Negative Regulation of Noncanonical NF-κB SignalingImmunity, 2012
- Fecal HMGB1 Is a Novel Marker of Intestinal Mucosal Inflammation in Pediatric Inflammatory Bowel DiseaseAmerican Journal of Gastroenterology, 2011
- Unravelling the pathogenesis of inflammatory bowel diseaseNature, 2007
- Extracellular HMGB1 as a Proinflammatory CytokineJournal of Interferon & Cytokine Research, 2004
- HMG-1 as a Late Mediator of Endotoxin Lethality in MiceScience, 1999